phrykt

Cme Group Inc. (CME): who owns it and who trades it

As of Nov 16, 2026, CME insiders reported 22 open-market sales worth $36.3M and 7 purchases worth $667K in the last 12 months, with 6% of the sale value made under pre-set 10b5-1 plans. The largest seller was Terrence A Duffy (CEO), with $21.3M. 10 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling CME Group

From the latest filings

Overall: more selling than buying. Insiders, famous investors and Congress mostly sold. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns CME

1,695 funds and institutions reported CME shares worth $71.6B at the end of Q2 2026. The largest holder is BlackRock, Inc. with $6.7B.

10 largest owners, by value

BlackRock, Inc.$6.7B
Vanguard Capital Management LLC$5.2B
State Street Corp$3.6B
Morgan Stanley$2.1B
Geode Capital Management, LLC$2B
Vanguard Portfolio Management LLC$2B
Capital World Investors$1.5B
JPMorgan Chase & Co$1.3B
Sanders Capital, LLC$1.1B
Norges Bank$1.1B

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.30.57M–$6.7B-3%
Vanguard Capital Management LLC23.66M–$5.2B+1%
State Street Corp16.35M–$3.6B+2%
Morgan Stanley9.73M–$2.1B+3%
Geode Capital Management, LLC9.27M–$2B+1%
Vanguard Portfolio Management LLC9.17M–$2B+2%
Capital World Investors6.82M–$1.5B-2%
JPMorgan Chase & Co5.77M–$1.3B–
Sanders Capital, LLC5.07M–$1.1B+22%
Norges Bank4.82M–$1.1B–
Ameriprise Financial Inc4.36M–$963M+17%
Raymond James Financial Inc4.06M–$896M-7%
FIL Ltd4.00M–$884M+18%
Bank of New York Mellon Corp3.93M–$867M-19%
Franklin Resources Inc3.83M–$846M+4%
Goldman Sachs Group Inc3.62M–$799M+1%
Northern Trust Corp3.48M–$770M-2%
Alphabet Inc.3.48M–$769MNo change
Royal Bank of Canada3.28M–$725M+11%
Arrowstreet Capital, Limited Partnership3.26M–$719M+26%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, CME insiders reported $667K of open-market purchases and $36.3M of sales. 6% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$667K
7 trades, 1 people
Sales, 12 months
$36.3M
22 trades, 13 people
Sales under a 10b5-1 plan
6%
Share of sale value
Latest trade
Nov 9, 2026
Filed Nov 10, 2026

Purchases and sales by month

$12.2M$12.2MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 9, 2026Daniel G KayeDirectorSale532$304.17$162KForm 4
Nov 2, 2026Howard J SiegelDirectorSale2,000$303.00$606KForm 4
Nov 2, 2026Julie WinklerSr MD Chief Commercial OSale10,079$305.15$3.1MForm 4
Oct 27, 2026Sunil CutinhoChief Information OfficeSale5,000$298.70$1.5MForm 4
Oct 22, 2026Martin J GepsmanDirectorSale400$302.50$121KForm 4
Sep 25, 2026William R ShepardDirectorPurchase293$268.76$78.6KForm 4
Sep 14, 2026Elizabeth A CookDirectorSale500$280.11$140KForm 4
Sep 10, 2026Terrence A DuffyCEOSale628$275.03$173KForm 4
Sep 10, 2026Terrence A DuffyCEOSale14,372$274.41$3.9MForm 4
Jun 25, 2026William R ShepardDirectorPurchase325$230.57$74.9KForm 4
Jun 25, 2026William R ShepardDirectorPurchase14$230.57$3.3KForm 4
May 18, 2026Hilda Harris PiellSr MD & Chief HR OfficerSale5,753$304.63$1.8MForm 4
May 15, 2026Terrence A DuffyCEOSale9,004$299.58$2.7MForm 4
May 15, 2026Terrence A DuffyCEOSale25,996$298.14$7.8MForm 4
Mar 26, 2026William R ShepardDirectorPurchase62$297.38$18.5KForm 4
Mar 26, 2026William R ShepardDirectorPurchase1,408$297.38$419KForm 4
Mar 17, 2026Jonathan L MarcusSr MD General CounselSale plan3,291$313.37$1MForm 4
Mar 17, 2026Jonathan L MarcusSr MD General CounselSale plan3,291$333.37$1.1MForm 4
Mar 12, 2026Ken VromanChief Transformation OffSale5,160$309.00$1.6MForm 4
Mar 6, 2026Elizabeth A CookDirectorSale1,000$320.00$320KForm 4
Feb 23, 2026Bryan T DurkinDirectorSale4,200$309.65$1.3MForm 4
Feb 20, 2026Martin J GepsmanDirectorSale300$305.90$91.8KForm 4
Feb 6, 2026Dennis SuskindDirectorSale748$300.00$224KForm 4
Dec 30, 2025William R ShepardDirectorPurchase11$278.37$3.1KForm 4
Dec 30, 2025William R ShepardDirectorPurchase251$278.37$69.9KForm 4
Dec 11, 2025Terrence A DuffyCEOSale13,089$269.10$3.5MForm 4
Dec 11, 2025Terrence A DuffyCEOSale11,911$270.05$3.2MForm 4
Nov 20, 2025Derek SammannSr MD Gl Hd Commodities Sale5,886$275.65$1.6MForm 4
Nov 20, 2025Derek SammannSr MD Gl Hd Commodities Sale1,314$275.74$362KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Terrence A DuffyChairman and CEO, Director–$21.3MSep 10, 2026
Julie WinklerSr MD Chief Commercial Officer–$3.1MNov 2, 2026
Jonathan L MarcusSr MD General Counsel–$2.1MMar 17, 2026
Derek SammannSr MD Gl Hd Commodities Mkts–$2MNov 20, 2025
Hilda Harris PiellSr MD & Chief HR Officer–$1.8MMay 18, 2026
Ken VromanChief Transformation Officer–$1.6MMar 12, 2026
Sunil CutinhoChief Information Officer–$1.5MOct 27, 2026
Bryan T DurkinDirector–$1.3MFeb 23, 2026
William R ShepardDirector$667K–Sep 25, 2026
Howard J SiegelDirector–$606KNov 2, 2026
Elizabeth A CookDirector–$460KSep 14, 2026
Dennis SuskindDirector–$224KFeb 6, 2026
Martin J GepsmanDirector–$213KOct 22, 2026
Daniel G KayeDirector–$162KNov 9, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

CME short interest

5.35M CME shares are sold short. Over the last 12 reports the number of shares short went up 12%.

As of Oct 30, 2026, 5.35M CME shares were sold short, up 7.3% from the report before. At the average daily volume of 2.21M shares, buying them all back would take about 2.4 trading days (days to cover).

Shares short

5.35MMay 15Oct 306.46M

Days to cover

2.4May 15Oct 303.7

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20265.35M–+7%2.21M2.4
Oct 15, 20264.99M–-10%1.93M2.6
Sep 30, 20265.53M–-5%1.74M3.2
Sep 15, 20265.80M–+3%1.74M3.3
Aug 31, 20265.63M–+8%1.99M2.8
Aug 14, 20265.20M–-16%1.68M3.1
Jul 31, 20266.21M–+6%2.76M2.3
Jul 15, 20265.84M–-3%3.11M1.9
Jun 30, 20266.01M–+15%4.85M1.2
Jun 15, 20265.21M–+14%4.17M1.2
May 29, 20264.57M–-5%2.69M1.7
May 15, 20264.78M–+17%2.29M2.1

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded CME

Since Nov 17, 2024, 7 members of Congress reported 7 purchases and 6 sales of CME. The latest was a sale by Gilbert Ray Cisneros, Jr. on Jun 16, 2026, reported Jul 2, 2026.

Purchases 7Sales 6

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
Jun 16, 2026Gilbert Ray Cisneros, Jr. (D-CA)Partial sale$1K–$15KSelfJul 2, 2026Report
Mar 27, 2026Alan Armstrong (R-OK)Purchase$1K–$15KSelfJul 21, 2026Report
Jan 9, 2026Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfFeb 13, 2026Report
Dec 18, 2025Julie Johnson (D-TX)Sale$1K–$15KJointJan 15, 2026Report
Nov 13, 2025Julie Johnson (D-TX)Partial sale$1K–$15KJointDec 11, 2025Report
Sep 23, 2025Val T. Hoyle (D-OR)Sale$1K–$15KSpouseOct 10, 2025Report
Aug 14, 2025Julie Johnson (D-TX)Partial sale$1K–$15KJointSep 11, 2025Report
Aug 11, 2025Julie Johnson (D-TX)Purchase$1K–$15KJointSep 11, 2025Report
Jul 22, 2025Julie Johnson (D-TX)Purchase$1K–$15KJointAug 14, 2025Report
May 21, 2025Val T. Hoyle (D-OR)Purchase$1K–$15KSpouseSep 12, 2025Report
May 12, 2025Jefferson Shreve (R-IN)Sale$15K–$50KSelfJun 22, 2025Report
Apr 8, 2025Robert P. Bresnahan, Jr. (R-PA)Purchase$1K–$15KSelfMay 8, 2025Report
Mar 10, 2025Carol D. Miller (R-WV)Purchase$1K–$15KSelfApr 11, 2025Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

CME Group company events

CME Group filed 12 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Oct 21, 2026.

  1. Oct 21, 2026ResultsReleased financial results. Filing
  2. Sep 25, 2026RulesChanged its bylaws or articles. Filing
  3. Sep 9, 2026LeadershipAs described in the attached press release, CME Group Inc. announced new senior leadership appointments in its finance and legal divisions. Filing
  4. Aug 11, 2026AnnouncementShared information with investors. Filing
  5. Jul 22, 2026ResultsReleased financial results. Filing
  6. Jun 17, 2026LeadershipCME Group Inc. announced that Terrence A. Duffy, the Company’s current Chairman and Chief Executive Officer, will become the Company’s Executive Chairman, and Lynne C. Fitzpatrick, the Company’s current President and Chief Financial Officer, will succeed Mr. Duffy as the Company’s Chief Executive… Filing
  7. Jun 10, 2026VoteReported shareholder vote results. Filing
  8. May 19, 2026VoteReported shareholder vote results. Filing
  9. Apr 27, 2026AgreementChicago Mercantile Exchange Inc. entered into an amendment to its 364-day multi-currency credit facility with Bank of America, N.A., in its capacity as Administrative Agent, Citibank, N.A., in its capacity as Collateral Agent and Collateral Monitoring Agent, and the banks party thereto. Filing
  10. Apr 22, 2026ResultsReleased financial results. Filing
  11. Feb 4, 2026ResultsReleased financial results. Filing
  12. Feb 2, 2026AnnouncementShared information with investors. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

CME Group financials

Famous investors that hold CME

10 of the 50 well-known investors we track reported holding CME in their latest 13F filing. The largest position is Ken Griffin's, worth $270M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 20261.03M$270M0.1%-32%
Seth Klarman · Baupost GroupQ3 2026685,435$180M3.6%+11%
Israel Englander · Millennium ManagementQ3 2026494,017$129M0.1%-59%
Jim Simons · Renaissance TechnologiesQ3 2026474,609$124M0.2%-30%
Steve Cohen · Point72 Asset ManagementQ3 2026441,297$116M0.2%-41%
Paul Tudor Jones · Tudor Investment CorpQ3 2026105,217$27.6M0.1%-59%
Tom Gayner · Markel GroupQ3 202649,750$13M0.1%No change
George Soros · Soros Fund ManagementQ3 202630,028$7.9M0.1%No change
Lee Ainslie · Maverick CapitalQ3 20262,530$663K0.0%New
Ken Fisher · Fisher Asset ManagementQ3 20261,392$365K0.0%-2%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Cme Group Inc. (CME) stock

Who owns the most CME stock?

The largest reported owner of Cme Group Inc. (CME) is BlackRock, Inc.. In total, 1,695 funds and institutions reported holding CME at the end of Q2 2026. See the largest owners.

Are CME insiders buying or selling?

In the last 12 months, CME insiders reported 7 open-market purchases worth $667K and 22 sales worth $36.3M. The latest trade was on Nov 9, 2026. See every trade.

What is the short interest in CME?

As of Oct 30, 2026, 5.35M CME shares were sold short, up 7.3% from the report before. At the average daily volume of 2.21M shares, buying them all back would take about 2.4 trading days (days to cover). See the history.

Have members of Congress traded CME?

Yes. 7 members of Congress reported 7 purchases and 6 sales of CME since Nov 17, 2024. The latest was reported on Jul 21, 2026. See the trades.

Which famous investors hold CME?

10 of the 50 well-known investors we track reported CME in their latest 13F filing, including Ken Griffin, Seth Klarman, Israel Englander. The largest position is worth $270M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.